杭氧股份在 2025 年二、三季度的业绩表现可能超出市场预期，主要基于以下 几个方面： 首先，管道气业务预计将带来显著增长。2024 年公司管道气收入 约为 60 亿至 70 亿元，今年（2025 年）预计将有明显增长，主要原因是去年 新投产了 65 万方左右的项目，设备固定量增速达到接近 30%。此外，高炉开 工率和产能利用率较高，汽车、家电等行业实施了大量国家补贴，以旧换新和 消费刺激政策，这些都推动了钢铁需求，从而维持了高水平的铁水产量和高炉 开工率。 其次，在零售业务方面，公司预计液体产能将增加约 30%。零售气 体价格方面，由于去年 6 月开始氮气、氧气和氩气价格快速下滑，今年（2025 年）三季度预计会出现同比增长。此外，今年（2025 年）供给端检修力度加 大，例如西北地区一些大型炼化企业进行了两到三年的大检修，对供给产生明 显影响。同时，储罐库容率较低，例如氮气库容率在今年（2025 年）5 月底为 32%左右，同比低 10 个百分点，这导致企业需要外购更多氮气，从而推高当 地价格。 最后，在设备业务方面，公司延续了去年以来的良好态势。整体来看， 今年（2025 年）的产业结构性变化以及供需不 ...

Core Viewpoint - The company has terminated the acquisition of Henan Keyi Gas Co., Ltd., which will not adversely affect its operational performance or financial status [3]. Group 1: Acquisition Details - The company announced the termination of the share acquisition agreement, which releases both parties from any obligations under the previous intention agreement [2]. - The initial plan was to acquire 65.43% of Henan Keyi, a company specializing in industrial gas production and sales, with a registered capital of 91.6785 million yuan [3]. - Henan Keyi's 2023 revenue was 227 million yuan, with a net profit of 24.4581 million yuan, and for the first half of 2024, it reported revenue of 90.9285 million yuan and a net profit of 8.0745 million yuan [3]. Group 2: Strategic Implications - The acquisition was aligned with the company's "14th Five-Year" strategic development plan, aimed at expanding into the industrial gas investment and operation sector [4]. - The company has a strong focus on cryogenic equipment manufacturing and aims to leverage this to enhance its capabilities in industrial gas production [4]. - The termination of the acquisition was due to a failure to reach consensus on key terms after extensive negotiations and due diligence [4]. Group 3: Financial Performance - In 2024, the company reported a revenue increase and a net profit of 72.3668 million yuan, representing a year-on-year growth of 121.67% [5]. - The growth was attributed to a significant increase in both existing and new orders, as well as effective collection of accounts receivable [5]. - The company plans to continue focusing on long-term development, actively pursuing market opportunities, and expanding into clean energy and industrial gas investment operations [5].

证券研究报告 氧氮价格拐点向上，液氧连续三周同比正增长 ——工业气体跟踪（6月） 行业评级：看好 2025年7月7日 | 分析师 | 邱世梁 | 分析师 | 王华君 | 分析师 | 李思扬 | | --- | --- | --- | --- | --- | --- | | 证书编号 | S1230520050001 | 证书编号 | S1230520080005 | 证书编号 | S1230522020001 | | 邮箱 | qiushiliang@stocke.com.cn | 邮箱 | wanghuajun@stocke.com.cn | 研究助理 | 张筱晗 | 工业气体：氧氮价格拐点向上，液氧连续三周同比正增长 ➢ 空分气价止跌回稳：6月，液氧/液氮/液氩均价位于历史28%/25%/10%分位值 2 1、中国工业气体行业近2000亿元市场，过去5年复合增速超过10%； 2、行业整合预期，龙头份额提升，竞争格局改善； 3、海外可比公司林德气体市值超万亿元； ➢ 电子气体：全球半导体景气逐步复苏；电子气体行业有望持续受益 1、半导体行业复苏进程中，电子气体是重要耗材； 2、自主可控，国产替代加速； 3、 ...

Group 1 - The article highlights the achievements and dedication of Yuan Yu, a skilled welder and technician at Chongqing Construction Non-Destructive Testing Company, emphasizing the importance of labor and craftsmanship in contributing to national development [1][8]. - Yuan Yu has obtained 11 special equipment operation certificates and has become one of the few young technicians capable of welding in high-risk industries such as chemical, military, and aerospace [2][4]. - The article details Yuan Yu's commitment to continuous learning and skill improvement, including his participation in various competitions and his innovative contributions to welding technology, which have resulted in significant cost savings for projects [4][6]. Group 2 - Yuan Yu's successful completion of a challenging project involving a 12-meter diameter, 25.5-meter high salt tank demonstrates his technical expertise and ability to tackle complex tasks [3]. - The article discusses the importance of welding robots in addressing the shortage of skilled welders and improving efficiency, quality, and material utilization in the industry [6]. - Yuan Yu's role as a mentor and trainer for over 4,800 welders, achieving a 99% pass rate for trainees, underscores the significance of knowledge transfer and skill development in the workforce [7][8].

吴清：将在科创板设置科创成长层 6月18日，中国证监会主席吴清在2025陆家嘴论坛中表示，将在科创板设置科创成长层，并且重启未盈 利企业适用科创板第五套标准上市，更加精准服务技术有较大突破、商业前景广阔、持续研发投入大的 优质科技企业。 上海超硅正是这样的优质科技企业：掌握关键核心技术，最近三年累计研发投入占营业收入比例为 15.21%，与全球前20大集成电路企业中的18家都建立了批量供应的合作关系，上海超硅，被业界称为 半导体"独角兽"。 上海科创集团科创策源经典案例： 坚定做好"长期资本""耐心资本" 集成电路大硅片是电子信息产业的"粮食"，"长周期""重资本""高技术壁垒"是行业的典型特征，硅片企 业需要经历长期的资本和研发投入，以及漫长和严苛的晶圆厂产品验证，最终深度嵌入产业链，进入盈 利周期，因此需要"长期资本""耐心资本"的支持。 上海科创集团作为上海超硅的重要股东，从2020年投资以来，始终陪伴其在集成电路关键领域从"基础 材料研发科创策源"到"先进规模化产能落地"，成为国际化的先进大尺寸硅片供应商。 上海证券交易所官网显示，2025年6月13日，上海国投公司旗下上海科创集团投资的上海超硅半导体 ...

近日，上海超硅半导体股份有限公司(以下简称"上海超硅")首次公开发行股票并拟在科创板上市的申请 已获上海证券交易所受理。公司本次IPO由长江证券承销保荐有限公司担任保荐机构，募集资金将重点 投向集成电路用300毫米薄层硅外延片扩产项目、高端半导体硅材料研发项目，并补充流动资金。 300mm大硅片产能爬坡助力盈利改善，国内市场空间广阔 替代逻辑明确 上海超硅长期聚焦于半导体硅片材料的研发和制造，主营产品覆盖300mm与200mm硅片，涵盖抛光 片、外延片、氩气退火片和SOI硅片等多个高端品类，系国内少数具备300mm大硅片完整制造能力的企 业之一。公司产品已量产应用于先进制程芯片，包括NAND Flash/DRAM(含HBM)/Nor Flash 等存储芯 片、逻辑芯片等多个主流芯片类型。 数据显示，半导体硅片市场在全球范围内保持增长，中国大陆半导体硅片市场亦步入了高速发展阶段， 2017 年至2022 年，中国大陆半导体硅片销售额从6.91 亿美元上升至22.15 亿美元，年均复合增长率高达 26.23%，远高于同期全球半导体硅片的年均复合增长率9.50%。 硅片是集成电路制造的基础材料，全球产业呈现高度集中 ...

Group 1 - The core viewpoint of the news is that Kefa Investment has conducted research on Hangyang Co., which is expected to have significant production capacity and strategic developments in the helium market by 2025 [1] - Hangyang Co. plans to produce 500,000 cubic meters of air separation units by 2025, involving multiple projects [1] - The company has made progress in the helium sector, achieving domestic substitution for liquid helium tanks and establishing a joint venture for helium sales [1] Group 2 - In 2024, Hangyang Co. will reduce its dividends to maintain financial stability [1] - The company is focusing on expanding its retail gas terminal rate and increasing the number of bottled gas filling stations [1] - The overseas equipment orders are expected to have a higher gross margin due to price advantages and tax rebate policies [1] Group 3 - The company is actively exploring opportunities in emerging markets such as the Belt and Road Initiative, Southeast Asia, Africa, and India [1] - Retail gas prices were low in the first quarter, but the company maintains stable earnings due to the cost advantages of liquid sales from pipeline gas [1] - The future price recovery of argon gas in 2024 will depend on economic recovery, the development of the photovoltaic industry, and market supply-demand conditions [1]

| 证券代码：688106 | | --- | 证券代码：688106 证券简称：金宏气体 公告编号：2025-029 转债代码：118038 转债简称：金宏转债 金宏气体股份有限公司 关于增加募投项目实施主体并使用部分募集资金向 新增实施主体提供借款以实施募投项目的公告 二、募集资金投资项目情况 截至2024年12月31日，公司本次可转换公司债券募集资金投资项目募集资金 使用情况如下： 单位：万元 | | 项目投资 | 拟使用募 | 截至2024年12 | 投入进度 | | --- | --- | --- | --- | --- | | 序号 | 项目名称 | | 月31日已投入 | | | | 总额 | 集资金额 | | （%） | | | | | 募集资金金额 | | 新建高端电子专用材料 项目 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 金宏气体股份有限公司（以下简称"金宏气体"或"公司"）于2025年5月 于增加募投项目实施主体并使用部分募集资金向新增实施主体提供借款以实施 募投项目的议案》，同意公司新增全资 ...

抗肿瘤领域近年来发展迅速，新型治疗方法不断涌现，鹏瑞利集团将联合南京瑞众生物科技不断探索抗 肿瘤创新疗法。新建医院将以肿瘤综合治疗为核心，同步布局分子核医学、核素内照射治疗和靶向治 疗、精准放疗等国际前沿领域，开展碘-125粒子植入治疗、氩氦刀冷冻消融术、DSA介入治疗以及肿瘤 免疫、靶向治疗等具有前瞻性的肿瘤新型疗法综合治疗各种实体恶性肿瘤。打破传统单病种诊疗模式， 将采用多学科联合诊疗（MDT）模式，为患者制定个体化治疗方案，推进肿瘤全程管理，形成"肿瘤专 科+多学科协作"特色。尤以甲状腺癌（手术+碘-131治疗）、肺癌、肝癌、胰腺癌、前列腺癌、脑胶质 瘤等作为主要攻克方向，选择最优的、精准的治疗路径进行治疗。不仅如此，采用"早筛-精查-微创干 预-长期随访"的全周期管理模式，依托于高精度影像检查（SPECT-CT、PET-CT等）及人工智能辅助诊 断系统，开展甲状腺结节及肺结节的精细化诊断和鉴别诊断，做到早发现、早治疗。 封面新闻记者 周家夷 近日，鹏瑞利集团与南京瑞众生物科技发展有限公司正式签署合作协议，拟投资1.5亿元建设以肿瘤专 科为核心特色的二级综合医院，项目落地成都鹏瑞利国际医疗健康中心，位于 ...

Investment Rating - The report maintains an "Outperform" rating for the basic chemical industry [2]. Core Viewpoints - The commercialization of humanoid robots is accelerating, with a focus on four major investment themes related to the chemical sector. In Q1 2025, over 35 companies launched new humanoid robot products, with more than 21 from China. The market for humanoid robots is expected to reach 8.239 billion yuan, accounting for about 50% of the global market by 2025 [5][28]. Summary by Sections Market Performance - The basic chemical industry index increased by 2.7% from April 18 to April 25, outperforming the Shanghai Composite Index by 2.1 percentage points and the ChiNext Index by 1.0 percentage points. Year-to-date, the basic chemical industry index has risen by 1.7%, surpassing the Shanghai Composite Index by 3.4 percentage points and the ChiNext Index by 10.8 percentage points [3][16]. Investment Themes 1. **Equity Investment Strategy**: The humanoid robot industry is projected to produce over 10,000 units by 2025, with significant market potential. Chemical companies can enhance their technological attributes through early-stage equity investments [5][28]. 2. **Polymer Materials**: Humanoid robots require various polymer materials, with modified plastics being a key solution for lightweight components. The demand for PEEK is expected to grow significantly, with a projected CAGR of 16.8% from 2022 to 2027 [5][29]. 3. **Tendon Materials**: Tendon systems are crucial for humanoid robots, with UHMWPE and carbon fiber being ideal materials due to their superior properties. Companies like Tongyi Zhong and Nanshan Zhishang are leading in UHMWPE production [5][6]. 4. **Electronic Skin Materials**: The electronic skin market is expected to grow from 6.3 billion USD in 2024 to 30 billion USD by 2034, with companies like Fulei New Materials and Hanwei Technology actively developing flexible sensor materials [5][6]. Product Price Changes - The report lists significant price changes for chemical products, with the top gainers including glyphosate (+16.3%) and liquid nitrogen (+13.7%). Conversely, coal tar saw a decline of 11.8% [5]. Investment Recommendations - Core assets in the chemical sector are entering a long-term value zone, with companies like Baofeng Energy and Wanhua Chemical recommended for investment. Additionally, sectors facing supply constraints, such as vitamins and refrigerants, are highlighted for their potential price elasticity [5][14][15].